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Abstract
To maintain genomic stability and ensure the fidelity of chromosomal transmission, cells respond
to various forms of genotoxic stress, including DNA double-stranded breaks (DSBs), through the
activation of DNA damage response signaling networks. In response to DSBs as induced by ionizing
radiation (IR), during DNA replication, or through immunoglobulin heavy chain (IgH)
rearrangements in B cells of lymphoid origin, the phosphatidyl inositol-like kinase (PIK) kinases
ATM (mutated in ataxia telangiectasia), ATR (ATM and Rad3-related kinase), and the DNA-
dependent protein kinase (DNA-PK) activate signaling pathways that lead to DSB repair. DSBs are
repaired by either of two major, non-mutually exclusive pathways: homologous recombination
(HR) that utilizes an undamaged sister chromatid template (or homologous chromosome) and non-
homologous end joining (NHEJ), an error prone mechanism that processes and joins broken DNA
ends through the coordinated effort of a small set of ubiquitous factors (DNA-PKcs, Ku70, Ku80,
artemis, Xrcc4/DNA lig IV, and XLF/Cernunnos). The PIK kinases phosphorylate a variety of
effector substrates that propagate the DNA damage signal, ultimately resulting in various biological
outputs that influence cell cycle arrest, transcription, DNA repair, and apoptosis. A variety of data
has revealed a critical role for p53-binding protein 1 (53BP1) in the cellular response to DSBs
including various aspects of p53 function. Importantly, 53BP1 plays a major role in suppressing
translocations, particularly in B and T cells. This report will review past experiments and current
knowledge regarding the role of 53BP1 in the DNA damage response.
Background
The p53 gene encodes a tumor suppressor whose primary
function is in transcription. p53 is inactivated or disrupted
in ≥50% of all human cancers. Mdm2, an E3 ubiquitin
ligase, interacts with the N-terminus of p53 and ubiquiti-
nates it, thus marking the protein for destruction by the
proteosome. ATM phosphorylates p53 in response to
DSBs, an event that prevents its Mdm2-mediated degrada-
tion and results in the stabilization and accumulation of
the protein [1,2]. Using the core DNA binding domain of
p53 (residues 80–320) as bait in a two hybrid screen,
Fields and colleagues first identified 53BP1 in 1994 [3].
Human 53BP1 is comprised of 1,972 residues and con-
tains important structural elements including two Breast
Cancer Gene 1 (BRCA1) C-terminal (BRCT) repeats, tan-
dem Tudor domains, a GAR methylation stretch, two
dynein light chain (LC8) binding sites, and numerous PIK
kinases and cyclin-dependent (CDK) phosphorylation
sites (Fig. 1). The sequences of 53BP1 that bind p53
include the C-terminal BRCT region. In vitro, the tandem
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BRCT repeats of 53BP1 (residues 1,724–1,972) bind core
p53 residues with a Kd of 6 μM as determined by isother-
mal titration calorimetry [4]. First identified in BRCA1,
BRCT motifs have been identified in a number of proteins
that are connected to DNA damage response mechanisms.
BRCT motifs have been reported to participate in various
processes such as transcriptional activation and they have
the capacity to serve as phospho-peptide binding modules
[5,6]. Because wild-type, but not mutant p53 (i.e. R175H)
binds 53BP1, the conformation of p53 appears crucial for
the 53BP1-p53 interaction [3]. To date, p53 is the only
factor reported to directly interact with any of the two
BRCT motifs of 53BP1. Subsequent transient co-transfec-
tion experiments with 53BP1 and p53 reporter plasmids
suggested that 53BP1 enhanced p53-mediated transcrip-
tion [7]. Another report suggesting a link between 53BP1
and transcription came with the identification of a 98
amino acid region of murine 53BP1 (corresponding to
human residues 1,179–1,277) that interacted with the
p202 transcription factor [8]. The significance of this
interaction remains uncertain.
The crystal structure of the recombinant BRCT motifs of
53BP1 and the central DNA binding domain of p53 (core)
has been solved [9,10]. Here, p53 binds to the N-terminal
BRCT motif and the linker region of 53BP1. Importantly,
the structural analysis also reveals that the same p53 resi-
dues are involved in binding both 53BP1 and DNA, mak-
ing it very difficult to imagine how 53BP1 could enhance
p53-mediated transcription. This point has been previ-
ously discussed by Halazonetis and co-workers [11].
Although it appears very unlikely that 53BP1 enhances
p53-mediated transcription as once suggested, one report
has concluded that 53BP1 positively regulates the BRCA1
promoter [12]. In this study, the p53-proficient U20S cell
line was co-transfected with siRNA molecules directed
against 53BP1 and a luciferase reporter construct under
the control of the minimal BRCA1 promoter. This resulted
in >70% inhibition of promoter activity [12]. Further-
more, using chromatin immunoprecipitation (ChIP)
assays, 53BP1 was shown to bind to an imperfect palin-
dromic sequence within the BRCA1 promoter element.
How 53BP1 regulates BRCA1 expression remains
unknown, but it is possible that its BRCT repeats possess
transactivation potential.
Implicating 53BP1 in the biology of p53 function
53BP1/p53 interactions at stalled replication forks
In addition to the initial binding studies between 53BP1
and p53, some recent evidence implicates 53BP1 in the
function of p53. Small interfering RNA (siRNA) knock-
down of 53BP1 in U20S cells revealed a delayed accumu-
lation of p53 in response to IR, an inducer of DSBs [13].
However,  53BP1-defective T cells, as generated from
knock-out mice (53BP1-/- ; see below), failed to show
altered levels of p53 accumulation in response to IR [14],
indicating possible differences in cell type and species.
Additionally, the expression of the two p53 target genes,
Mdm2 and p21, was normal in 53BP1-/- thymocytes [14],
further illustrating the unliklihood that 53BP1 acts as a
transcriptional co-activator of p53. However, in a pathway
dependent upon activation of Chk1, 53BP1 was shown to
regulate the accumulation of the ReqQ helicase BLM and
p53 to sites of stalled replication forks [15]. In addition to
the well described role of p53 as a transcription factor, the
protein has also been shown to mediate recombination
events through its recruitment to stalled replication forks
and other abnormal DNA structures (i.e. Holliday junc-
Human 53BP1 is composed of 1,972 amino acids and contains several noteworthy structural features as discussed throughout  the text Figure 1
Human 53BP1 is composed of 1,972 amino acids and contains several noteworthy structural features as discussed throughout 
the text. p53 binds to the N-terminal BRCT motif and linker sequence of 53BP1. 53BP1 possesses numerous PIK phosphoryla-
tion sites (S/TQ) and is phosphorylated on serine residues 25 and 29 in vivo. Like BRCA1 and Mdc1 and the yeast Rad9 and 
Crb2 proteins, 53BP1 possesses two repeating C-terminal BRCT motifs. In addition, 53BP1 contains a tandem tudor domain, a 
stretch rich in glycine and arginine residues (1396–1403) that is methylated by the PRMT1 arginine methyltransferase in vivo 
and in vitro, LC8 binding sites and two potential KEN boxes (aa 54–60 and 85–91), sequences known to interact with the ana-
phase promoting complex (APC).Cell Division 2006, 1:19 http://www.celldiv.com/content/1/1/19
Page 3 of 13
(page number not for citation purposes)
tions) in a manner dependent upon BLM [15]. Thus,
53BP1 is required for the localization of p53 to stalled
replication forks.
53BP1/p53 and dynein motors
Another biochemical link between 53BP1 and p53 has
been uncovered in experiments designed to understand
the dynein microtubule motor complex [16]. Previous
studies demonstrated that p53 undergoes cytoplasmic
dynein-dependent nuclear translocation in response to
DNA damage. Because p53 is not known to bind directly
to the dynein motor complex, Zhang and colleagues
hypothesized that adaptor proteins would tether p53 to
the minus-end directed microtubule motor complex [16].
To identify such factors, a two-hybrid screen using the
dynein 8 kD light chain protein (LC8) as bait was per-
formed. Here the investigators found that LC8 robustly
binds 53BP1 in vitro. In fact, 53BP1 contains two tandem
LC8-binding motifs (Fig. 1). Thus, 53BP1 has been pro-
posed to link p53 to the microtubule motor complex
through its dynein binding capacity. How this relates to
the previously described localization of 53BP1 to the
kinetochore [17,18] is not clear.
Influence of 53BP1 on Mdm2/p53 signaling
Because roughly one half of all tumors have wild-type p53
activity, one approach for activating and stabilizing p53 in
tumor cells could involve disrupting the Mdm2-p53 inter-
action. This would be expected to induce a cell cycle arrest
in apoptosis-resistant tumor cells. In this regard, p53 func-
tion is a key target for therapeutic intervention. The small
molecule nutlin-3 has been shown to abrogate the Mdm2-
p53 interaction leading to p53 stabilization [19].
Recently, a loss-of-function genetic screen designed to
identify components of the p53 network that mediate the
cytotoxic effects of nutlin-3 in human tumor cells identi-
fied 53BP1 [20]. Here, an siRNA bar code screen using the
p53 proficient MCF-7 cell line identified 53BP1  as an
essential gene for the drug-induced phenotype, a result
that provides further evidence for a connection between
53BP1 and p53. Thus, 53BP1 mediates the antiprolifera-
tive effects of nutlin-3, a finding the authors suggest indi-
cates that intrinsic DNA damage signaling in MCF-7 cells
(and hence 53BP1 activity) is required for nutlin-3 cyto-
toxicity [20]. This provides strong evidence for a role for
53BP1 in the biology of p53 and Mdm2 in MCF-7 cells.
These authors also found that the deubiquitanase USP28
also participated in nutlin-mediated cytotoxicity. USP28
has been recently been shown to regulate the Chk2-p53-
PUMA pathway and this is particularly of interest as
USP28 has been identified as a 53BP1-binding protein
([21]; Table 1). These two studies clearly show that 53BP1
functions in the biology of p53. Although USP28 has
been proposed to use 53BP1 as a substrate, ubiquitylated
53BP1 has not been detected [21].
53BP1: focusing on mediating the DNA damage 
response through ATM signaling
In response to IR, the histone variant H2AX is rapidly
phosphorylated by PIK kinases and relocalizes to sites of
DNA damage [22,23]. The accumulation of phosphor-
ylated histone H2AX (γ-H2AX) at and near sites of DSBs
can be detected cytologically as irradiation induced foci
(IRIF) [22,23]. Using antibodies against human and Xeno-
pus 53BP1, several labs found that 53BP1 forms IRIF in
response to genotoxic stress, particularly agents that
induce DSBs [24-27]. Such foci overlap with those previ-
ously described for H2AX and Mre11. Moreover, 53BP1
possesses numerous PIK kinase phosphorylation sites (S/
TQ) and was shown to be a substrate for ATM and proba-
bly its related kinases [24,25,27]. 53BP1 phosphoryla-
tion, however, is not required for IRIF formation [28],
although it clearly represents an activating event. Based
upon these observations, 53BP1 was proposed to operate
in DSB repair. Indeed, 53BP1 has been shown to physi-
cally associate with a number of proteins involved in var-
ious aspects of DSB repair (Table 1). A further glance into
the functional role of 53BP1 in DNA damage signaling
came with the analysis of mammalian cell lines depleted
in 53BP1 expression through siRNA or from knock-out
mice (see below) [13,29,30]. These cells revealed that
53BP1 was required for the optimal, DNA damage-induc-
ible phosphorylation of ATM substrates such as Smc1,
Chk2, and BRCA1 [13,29,30]. Furthermore, 53BP1-defi-
cient cells have been reported to have a mild intra-S phase
(RDS phenotype) and a nearly three-fold defect in the G2/
M checkpoint, but only at low doses of IR [13,29]. One
study showed that 53BP1-/-  cells had a prolonged G2
phase, a phenotype also reported in ATM-deficient cells
[30]. This suggested that 53BP1 mediated the DNA dam-
age response by facilitating ATM activity towards at least a
subset of its substrates and raised the possibility that
53BP1 could function in ATM activation, an event that is
likely to be tightly coupled to chromatin structure and
function [11,29].
How cells sense and respond to DSBs has been the subject
of intense research by numerous laboratories. Because the
DNA repair apparatus uses damaged DNA as a substrate,
the DNA damage response must be tightly linked to chro-
matin structure and function. In response to DSBs, the
Mre11/Rad50/Nbs1 (MRN) complex is rapidly recruited
to sites of DNA breaks [31,32]. In budding yeast, the
Mre11 complex facilitates nucleosomal displacement near
the DSB and H2A phosphorylation [33]. Here, loss of
H2B and H3 also depends on the Ino80 chromatin
remodeling complex [33]. In fact, ChIP analysis reveals
that phosphorylated H2A in budding yeast is not associ-
ated with the break per se, but rather the Mre11 complex
appears to localize to sites of DNA damage [34]. This is
believed to contribute, at least in part, to ATM activationCell Division 2006, 1:19 http://www.celldiv.com/content/1/1/19
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[35,36]. In addition, autophosphorylation of ATM, partic-
ularly at S1981 (S1981-P), has been linked to its activa-
tion where it occurs in response to DNA damage and
changes in chromatin structure [37]. However, the role of
S1981 phosphorylation is not clear because mice deficient
in the mutant appear largely normal for several ATM func-
tions, including those that occur in B and T cells [38]. ATM
activation, as measured by S1981 autophosphorylation,
also occurs in response to changes in chromatin structure
in the apparent absence of DNA breaks [37]. Moreover,
the MRN complex is also believed to contribute to the
activation of ATM kinase [35,36]. Acetylation of ATM by
Tip60 has also been attributed to its activation [39]. Thus,
ATM activation appears to be a highly regulated event
where autophosphorylation at S1981 may represent just
one facet of its activation.
ATM phosphorylates and contributes to the activation of
a number of important DNA damage response regulators.
In response to IR, ATM phosphorylates 53BP1 on serine
residues 25 and 29 [28]. Importantly, ATM phosphor-
ylates the C-terminal tail of H2AX, generating γ-H2AX
which directly recruits and binds Mdc1 (formerly known
as NFBD1), a factor that, like 53BP1, contains two C-ter-
minal BRCT repeats in addition to a forkhead domain
[40-42]. Through the BRCT motifs of Mdc1, the γ-H2AX-
Mdc1 complex recruits another ATM molecule, thus
amplifying the original DNA damage response signal
through the creation of a positive feedback loop [40-44].
As a consequence, neighboring H2AX molecules that
reside in a subset of histone octamers peripheral to the
DNA break become phosphorylated, resulting in the gen-
eration of γ-H2AX molecules that lie up to one megabase
from the actual site of the DNA break.
A variety of proteins, including 53BP1, have been shown
to localize to IRIF in many cell types. In lymphoid B cells,
53BP1 localizes to the switch locus of murine chromo-
some 12 [14,45]. The precise biological role of IRIF is
unknown, but they are in all probability associated with
DNA repair. Indeed, the accumulation of H2AX to IRIF is
routinely used as a marker for DSBs. Because many cancer
Table 1: Summary of proteins known to interact with 53BP1.
Protein Comments References
p53 53BP1 was discovered as a protein that binds to the central core DNA binding domain of p53 in a 
yeast two-hybrid assay.
[3]
RIF1 53BP1 is required for IRIF formation of RIF1, a human homolog of a yeast telomeric protein that 
participates in the intra S-phase checkpoint.
[104]
RPA2 53BP1 co-immunoprecipitates with RPA2, single-stranded DNA binding complex. Association is IR 
dependent.
[105]
Jab1 Jab1 was shown to bind to 53BP1 in a yeas two-hybrid screen. Jab1 may be responsible for the 
observed hyperphosphorylation of 53BP1 in M phase in response to nocodazole.
[93]
Dynein LC8 53BP1 possesses two tandem LC8 binding sites (Fig. 1) and may bind to the dynein motor complex 
protein in a manner that regulates p53 function.
[16]
BRCA1 53BP1 is required for optimal IR-inducible phosphorylation of BRCA1 at S1472; 53BP1 is part of the 
"BASC" complex and interacts with other components of this complex.
[13, 106]
Chk2 53BP1 is possibly required for optimal Chk2 phosphorylation at T68 in response to IR. [13, 29]
H2AX A fragment of 53BP1 containing residues 956–1354 were reported to bind phosphorylated peptides 
corresponding to the C-terminal tail of γ-H2AX.
[107]
Mdc1 53BP1 binds to the BRCT repeat protein Mdc1. 53BP1 IRIF formation is dependent upon functional 
Mdc1.
[38–40, 50]
Smn1 53BP1 co-localizes with and co-immunoprecipitates with Smn1, an Artemis-like protein. [108]
Artemis 53BP1-Artemis interactions were reported from cells transfected with 53BP1 expression vectors [88]
ATM 53BP1 has been reported to co-immunoprecipitate with ATM. 53BP1 is clearly an ATM substrate, but 
may also participate upstream of ATM activation
[11, 23, 26, 28, 58]
Histones H3 and H4 The tandem Tudor domains of 53BP1 have been reported to bind various methylated states of 
histones H3 and H4 as discussed in the text.
[58, 60]
Rad51 Although 53BP1 does not appear to function in break-induced IR, it has been detected to co-localize to 
I-SceI induced DSBs.
[52, 53]
HDAC4 53BP1 and HDAC4 bind together and co-localize to IRIF. The stability of 53BP1 depends on HDAC4 
and vice versa.
[18]
PTIP PTIP shows increased association with 53BP1 in response to IR and in an ATM-dependent manner. 
Amino acids 1052–1710 of 53BP1 are necessary for interaction with PTIP.
[41]
USP28 Deubiquitinase that binds to 53BP1 and controls Chk2-p53-PUMA pathway. Also, mediates cytotoxic 
effects of nutlin, a molecule that influences p53 stability.
[20, 21]
53BP1 interacts with various factors implicated in maintaining genomic stability through their control of DSB repair, cell cycle checkpoints, and 
chromatin structure. Partial summary of proteins, listed in no particular order, reported to interact with 53BP1 throughout various in vitro and in 
vivo techniques including yeast-two hybrid assays and co-immunoprecipitation. See text for more details.Cell Division 2006, 1:19 http://www.celldiv.com/content/1/1/19
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cells and tissues exhibit constitutive 53BP1 foci, activation
of DNA damage response pathways may be an early fea-
ture in human tumorigenesis, probably as a consequence
of the intrinsic genomic instability in these cells [46,47].
This could provide a selection for p53 loss during tumor-
igenesis and has been proposed to explain the large fre-
quency of p53 mutagenesis in cancer [47]. Indeed, loss of
53BP1 function correlates with cancer progression in
human tumors [46,47]. How widespread 53BP1 dysfunc-
tion is in human tumors has not been thoroughly
addressed. Interestingly, a human patient with a myelo-
proliferative disorder was found to have a translocation
that generated a fusion protein between 53BP1 and the
platelet-derived growth factor (PDGF; [48]). Because, in
this scenario, PDGF tyrosine kinase activity depends on
the ability of its fusion partner sequences to form oligom-
ers, it was proposed that 53BP1 could form oligomers
[48]. Indeed, 53BP1 oligomerizes in vivo, but the signifi-
cance of this remains unknown [49].
Although some siRNA studies concluded that 53BP1 and
Mdc1 IRIF formation occurs independently of each other
[40,50,51], it is now clear that both γ-H2AX and Mdc1 are
required for the accumulation of 53BP1 to IRIF
[41,42,52]. In addition, the histone acetyltransferase
(HAT) co-factor Trrap and HAT Tip60 complex (Trrap-
Tip60) is required for 53BP1 IRIF formation [53]. Trrap-
Tip60 binds to chromatin near DSBs and Trrap-deficient
cells are impaired in break-induced HR [53], underscoring
the intimate link between DNA repair and chromatin
structure (see below). Since Trrap is required for 53BP1
IRIF formation and influences HR [53], does this necessar-
ily mean that 53BP1 functions in break-induced HR?
Apparently not, as 53BP1 plays no role in this process
when tested with in an I-Sce I-based system developed in
the Jasin laboratory that measures gene conversion [54].
Despite this, ChIP experiments indicate that 53BP1 local-
izes with the Rad51 paralogs Rad51A and Rad51C to I-
SceI-induced DSB foci [55]. Moreover, in the absence of
extrinsic DNA damage, 53BP1 localizes to "nuclear dots"
during S/G2 [53], a phenomenon similarily reported for
Rad51 and BRCA1 [56]. Unlike 53BP1, H2AX and Mdc1
have been reported to participate in HR [54,57,58], fur-
ther illustrating the differences between regulators of DSB
repair pathways. 53BP1-/- fibroblasts, however, display a
hyper-rec phenotype, suggesting that the protein sup-
presses aberrant, spontaneous recombination (as
opposed to break-induced HR). Clearly, 53BP1 does not
act redundantly with H2AX and Mdc1 during the DNA
damage response.
Linking 53BP1 function with chromatin 
structure
Although unlikely to be a structural component of chro-
matin, 53BP1 possesses several intriguing links to the
biology of chromatin, particularly with respect to the reg-
ulation of histone modifications [59,60]. IR-inducible
phosphorylation of 53BP1, which likely represents the
"active" protein, associates with chromatin [61]. In terms
of CSR in B cells, one possibility is that 53BP1 synaptic
function provides a scaffold for coordinating DNA repair
through modulating chromatin structure in the language
of a histone code. First, in addition to the well docu-
mented role of γ-H2AX-dependent recruitment of 53BP1
to IRIF, 53BP1 possesses tandem Tudor motifs (53BP1TT)
[59,60] which have been reported to associate with vari-
ous methylated lysine residues in histones H3 and H4
[60,62]. This includes lysines K4, K9, and K20 in histone
H4 and H3 K79 (by the Dot1 methyltransferase). Intrigu-
ingly, in fission yeast, methylation of histone H4 at K20
has been linked to DNA repair through its interaction
with Crb2 [63], a potential 53BP1 orthologue (see
below). No such function for H4 K20 has been reported
in mammalian cells. Tudor motifs resemble chromodo-
mains at the structural level and associate with methylated
arginine and lysine residues [64]. For example, 53BP1TT,
the minimal region of the protein sufficient for IRIF for-
mation, binds to H3 K79-CH3 independently of DNA
damage [60]. Although this modification is constitutive,
lysine 79 is sterically inaccessible under normal condi-
tions as it lies in the nucleosome core. Because of this,
53BP1 has been proposed to sense changes in chromatin
structure that occur "upstream" of the DNA break [60]. In
this regard, a perturbation in chromatin structure, as
introduced through a nearby DSB, is thought to expose
H3-K79-CH3 and allow for 53BP1 binding and execution
of its essential functions in DSB repair. Indeed, 53BP1
apparently binds H3-K79-CH3 under conditions that per-
turbed chromatin structure without introducing DSBs
[60]. In the case of isotype switching in activated B cells,
53BP1 activation could be induced through transcrip-
tional events that alter chromatin structure prior to the
genesis of AID-dependent DNA breaks. Thus, recruitment
of 53BP1 to chromatin during DSB repair may proceed
through multiple histone modifications and is likely con-
nected to its role in a non-classical form of end joining
("anchoring") [65].
As it operates early in the DNA damage response and asso-
ciates with modified histones, 53BP1 is a strong candidate
for participating in both DSB repair and chromatin
remodeling in the vicinity of the break or in response to
other types of chromatin perturbation. In this manner,
DNA repair by 53BP1 is coordinated with IRIF factors like
H2AX and Mdc1 in conjunction with its ability to influ-
ence chromatin architecture. Previous studies have indi-
cated that in response to DNA damage yeast H2A recruits
chromatin remodeling complexes [66-68]. Additional,
non-mutually exclusive mechanisms may also be opera-
tive in this process. For example, the PRMT1-dependentCell Division 2006, 1:19 http://www.celldiv.com/content/1/1/19
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methylation of 53BP1 at arginine residues [49,69] within
its GAR motif (Fig. 1) may form an epigenetic signal that
participates in 53BP1 function. However, GAR methyla-
tion does not influence DNA binding or IRIF formation
by 53BP1 [49]. Furthermore, 53BP1 protein levels are
reciprocally regulated by the histone deacetylase 4
(HDAC4; [68]). Because one might anticipate that chro-
matin near a DSB would exist in a "relaxed" form that per-
mits the DNA repair apparatus access to the sites of
damage [70], perhaps 53BP1 activity influences acetyla-
tion levels through HDAC4 function.
53BP1 and DNA end joining: lessons from 
lymphocytes
53BP1 mouse models
Key functional insight into the role of 53BP1 in DSB
repair has been gained from studying murine T and B cells
in 53BP1-defective (53BP1-/-) mice. The first two descrip-
tions of 53BP1-/- animals were reported from the Chen
and Carpenter labs [30,71]. Both animals appear to be
null mutations and possess very similar, but not identical,
phenotypes. A third 53BP1-/-  mouse model has been
reported but has not been thoroughly characterized [72].
In one mouse model, 53BP1 has been reported to func-
tion as a haploinsufficient tumor suppressor [14]. Previ-
ous studies with H2AX/p53  double mutant animals,
which develop T and B lineage tumors, also showed a hap-
loinsufficient phenotype for H2AX in tumor suppression
[73,74]. Because the H2AX variant resides in up to 30% of
histone octamers, haploinsufficiency was argued to reflect
a role of the protein as a structural component of chroma-
tin [73,74]. Interestingly, 53BP1-/- mice resemble, in some
important ways, H2AX-/- and ATM-/- mice as well as the
recently described Mdc1-/- mice (Table 2[41,75-77]). Like
H2AX-/-  and  ATM-/-  mice,  53BP1-/-  mice are growth
retarded, sensitive to IR, and immune deficient [41,75-
77]. In contrast to ATM-/- mice which die of T cell lympho-
mas with clonal translocations, 53BP1-/- and H2AX-/- mice
are mildly tumor prone [30,71]. 53BP1-/- animals are fer-
tile and have reduced thymus cellularity [30,71]. Lack of
53BP1 function results in mice that are immune deficient
as they are severely impaired in performing the B cell-
specifc process of IgH class switch recombination (CSR or
isotype switching) [54,78].
DNA repair in immune development
During the development of the immune system, both T
and B cells use NHEJ to assemble the exons encoding
immunoglobulins (Igs) and T cell receptors (TCR) by
V(D)J recombination [79,80]. Additionally, mature B
cells may express different Ig constant regions through the
process of CSR, a DSB-mediated, end-joining event that
requires successful completion of V(D)J recombination,
germline transcription through the switch (S) locus on
murine chromosome 12, and cell proliferation (Fig. 2)
[79]. CSR is an inducible event that occurs at a defined
(and very important) chromosomal location and there-
fore represents a unique system for examining DNA repair
and related processes in mammalian and lymphoid cells.
Although V(D)J recombination and CSR are both DSB
repair events that are completed by any of several ubiqui-
tous NHEJ proteins, they require a different set of overall
factors (Fig. 2) [79,81-84]. For example, DSBs in V(D)J
recombination are initiated by the RAG endonuclease, but
CSR is initiated by the activation induced deaminase
(AID) [79,81-84]. By deaminating cytosine to uracil, AID
activity induces DNA repair pathways that result in the
formation of DSBs throughout the switch locus, as the
uracil residues are thought to be processed into DSB inter-
mediates [79,81-84]. During CSR, multiple AID-derived
DSBs may occur within the S region, leading to both inter-
nal deletions and those repair events that properly join S
region DNA fragments leading to productive isotype
switching. Because S regions that lie up to approximately
Table 2: Tumor susceptibility in mice defective in 53BP1 and related DNA damage response genes.
Defective Gene(s) B cell lymphoma T cell lymphoma References
53BP1 None Low-mild [29, 69]
p53 None All aneuploid with no clonal breaks [109–111]
53BP1/p53 t(12;15) translocations that amplify c-myc Aneuploidy and clonal translocations that include TCRα locus [14, 85]
H2AX None Low-mild [73, 74]
H2AX/p53 t(12;15) translocations that amplify c-myc 75% of animals clonal translocations; H2AX+/-p53-/- animals are 
aneuploid or possess clonal translocations
[71, 72]
NHEJ None None [77]
NHEJ/p53 Pro-B cell lymphoma None [77, 89–92]
Mdc1 None Low [39]
ATM None 100% of animals with clonal translocations at TCR locus of 
chromosome 14
[75]
Phenotypes of 53BP1 -deficient murine animals relative to those of its related DSB repair factors with particular emphasis on tumor susceptibility. 
Murine animals defective in 53BP1 function share overlapping features to H2AX, Mdc1 and ATM -deficient animals in that they are growth retarded, 
sensitive to IR and immune deficient as they are impaired in isotype switching. Like H2AX and any of several components of the NHEJ apparatus, 
53BP1-/- animals are relatively non-tumor prone unless combined with p53 deficiency. See text for details.Cell Division 2006, 1:19 http://www.celldiv.com/content/1/1/19
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100 kB away from each other they are likely to be brought
into close physical proximity during synapsis to ensure a
productive recombination events and successful isotype
switching. Chromosomal translocations involving the
immunoglobulin switch region are feature of B cell malig-
nancies and therefore understanding how DNA repair fac-
tors like 53BP1 function will provide important insight
into the mechanisms of translocation-induced tumori-
genesis.
Defective DNA repair in 53BP1-/- B cells reveals a major 
role in the end joining process of CSR
Through various measurements, 53BP1 appears largely,
but probably not exclusively, dispensable for V(D)J
recombination at T cell receptor (TCR) and IgH loci
[54,78]. 53BP1, however, plays a major role in the B cell-
specific process of CSR [54,78]. DNA repair at IgH during
CSR represents a specialized form of DSB repair that pro-
ceeds through H2AX and 53BP1-mediated pathways
Class-switch recombination is a NHEJ event involving the exchange of heavy chain constant regions with the previously assem- bled V(D)J exons Figure 2
Class-switch recombination is a NHEJ event involving the exchange of heavy chain constant regions with the previously assem-
bled V(D)J exons. AID induces lesions at the switch regions (circles) upstream of a given IgH gene which are converted to 
DSBs. These DSBs recruit various factors, including Mre11/Nbs1/Rad50, that are important for the resolution of the break. 
The end result of CSR is the replacement of the mu exon with another constant region gene (IgG1 shown). 53BP1 performs an 
anchoring role at the IgH locus during this process that might involve interactions with nucleosomes near the break through 
various histone modifications (see text for details). This is thought to modulate chromatin in this area to facilitate DNA repair.Cell Division 2006, 1:19 http://www.celldiv.com/content/1/1/19
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[54,75,76,78,80], CSR depends on S region transcription
and recombination is targeted to individual S regions
from transcription that occurs from intronic promoters
[79,82]. Through coordinated synapses over long ranges,
CSR serves as a regulated DNA repair event in B cells that
operates in close association with S region transcription
and AID activity. It is now very clear that secondary iso-
type formation through CSR is severely reduced in 53BP1-
/- B cells [54,78]. In fact, this DNA repair defect is more
severe than those deficiencies observed for ATM, H2AX,
and Mdc1 defective B cells [82,84]. In those rare cases
where  53BP1-/- B cells did successfully perform isotype
switching, the sequence junctions at Sμ-Sγ1 appeared nor-
mal, indicating that defects in 53BP1 function do not
influence resolution of the repair event [78]. Moreover,
since 53BP1-/- B cells proliferate normally, are competent
for S region transcription, and have wild-type levels of
AID expression, the CSR defect in these cells was clearly
not due to the initiation or resolution of the DNA break.
The DSB defect was therefore proposed to occur at the
level of synapsis, or DNA end joining [78]. Consistent
with this, a PCR strategy that amplifies DNA only after
productive CSR events have taken place showed that the
defect in 53BP1-/- B cells occurred at the level of recombi-
nation [78]. Thus, in B cells, 53BP1 participates in DNA
end joining during CSR probably through an end joining-
like function. Because the RAG complex possesses synap-
tic activity, this could obviate or reduce the need for
53BP1 function during V(D)J recombination. These
results regarding a synaptic function for 53BP1 were inter-
esting in light of a prior report that showed that a recom-
binant fragment of human 53BP1 encompassing residues
within the kinetochore binding domain (Fig. 1) stimu-
lated dsDNA end joining activity by XRCC4/LigIV, but not
T4 ligase in vitro [61]. A more recent study using the
chicken B cell line DT40 has confirmed a major role for
53BP1 in end joining [85]. In addition, previous reports
suggested that H2AX tethers broken chromosome ends
through long range synapsis at S regions [45,73,74] lead-
ing to the proposal that H2AX participates in an end join-
ing process distinct from classical NHEJ, termed
"anchoring" [86]. Similarly, 53BP1 has been proposed to
operate in a non-classical, or alternate form of end joining
[65,78]. In this capacity, H2AX and 53BP1 facilitate DNA
repair of broken chromosomes by anchoring DNA ends in
preparation for end processing and ligation by the NHEJ
apparatus, an activity that can suppress translocations.
To further illustrate a role for 53BP1 in DNA end joining,
a two-color FISH assay using probes designed to hybridize
to sequences external to the V(D)J and CSR regions was
used [87]. Under wild-type conditions where CSR is nor-
mal and DNA repair is intact, two distinct, essentially
non-overlapping FISH signals (red and green) are readily
seen at the Igh locus in metaphase spreads [87]. In con-
trast, a failure to repair DSBs induced at IgH would result
in "split signals" as the telomeric-proximal FISH signal
would be separated from the remaining chromosome. In
the case of 53BP1-/- B cells, a significant number of "split"
signals as seen by single red and green spots was observed
[87]. The number of split signals was dependent on AID
function [87], indicating that in the absence of 53BP1
function, AID-induced DSBs generate chromosomal
breaks refractory to repair [87,88]. Similar conclusions
were reached from experiments using H2AX-/-,  Mdc1-/-,
and ATM-/- B cells [87,88]. Some 53BP1 breaks progressed
into chromosome 12-derived translocations (i.e. Igh-c-
myc) [87,88]. An increase in chromosome 12 dicentrics
was also observed (CSR often occurs on both alleles). In
conclusion, 53BP1 deficiency results in the inability to
"anchor" chromosomal breaks and creates a cellular con-
text permissive for the genesis of translocations.
53BP1, H2AX, Mdc1, and ATM have similar phenotypes
and physically interact. Therefore, these factors likely
function in a common biochemical pathway that sup-
presses translocations, particularly in cells of lymphoid
origin. In the absence of 53BP1 activity, the failure to
"anchor" or perform non-classical, alternate end joining
function triggers an ATM-dependent signaling pathway
that activates p53 for cell cycle arrest (and/or apoptosis)
(Fig. 3) [87,88]. In addition, AID-dependent, unrepaired
DSBs may also be repaired through translocations (partic-
ularly to c-myc), which are suppressed by ATM and p19
signaling pathways [88]. Interestingly, the majority of
genomic instability in 53BP1-/- B cells occurs at the IgH
locus suggesting that this factor performs a very specific
role in CSR. One striking feature of 53BP1 deficiency in
fibroblasts, T cells, and B cells is the apparent lack of
genomic instability in unchallenged cells [71,87,89].
When 53BP1-/- B, T, or fibroblast cells are treated with IR
or during DNA repair in lymphoid cells, increases in
breaks, gaps, and translocations become apparent
[87,89]. This feature of 53BP1 distinguishes it from H2AX,
Mdc1, and ATM deficiencies which are characterized by
more severe forms of genomic instability in resting cells
[41,87,88]. Despite this, the CSR defects in H2AX-/- and
ATM-/- genetic backgrounds are moderate compared to the
severe phenotype observed in 53BP1 deficiency. Why
53BP1-/- B cells have profound defects in CSR is currently
unknown, but it could be related to the nature of the
repair process itself. For example, one study has suggested
that focus forming proteins like 53BP1 collaborate with
ATM and Artemis to resolve complex DNA end structures
(i.e. those that cannot be directly ligated) through end
joining [90]. Although, its role in V(D)J recombination
has been well described [79,80], Artemis is not required
for CSR [91]. Such difficult DNA repair substrates might
be expected to occur for a small subset of DSBs and this
was proposed to explain the reasons underlying the radi-Cell Division 2006, 1:19 http://www.celldiv.com/content/1/1/19
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osensitivity in Artemis-defective fibroblasts, although
defects in cell cycle checkpoints may also be an important
determinant of this [92]. If CSR at the IgH locus can be
considered a complex form of DSB repair due to the unu-
sual method for generating breaks by AID and because of
the long-range synapses generated during repair, this
could undelie the strong phenotype of 53BP1 in CSR.
53BP1 and p53 synergize in tumor suppression
Murine animals defective in 53BP1,  H2AX,  Mdc1, and
NHEJ components are relatively non-tumor prone, a
result that is probably due to intact p53 surveillance
mechanisms (Table 2). Mice defective in p53 have been
well described: at an average age of 5 months, 75% of the
animals die of T cell lymphomas characterized by their
aneuploid nature with little signs of clonal DNA translo-
cations [73,74]. B cell lymphomas are very rare in p53 nul-
lizygous mice. However, when combined with mutations
in  p53, NHEJ/p53, H2AX/p53, and 53BP1/p53  double-
mutant animals rapidly die of T and/or B cell lymphomas
[14,73,74,89,93,94]. Tumorigenesis occurs as early as 7
weeks under these conditions and has been demonstrated
to be mechanistically distinct from p53 due to its altered
timing and change in tumor spectrum [73,74,89,93,94].
NHEJ/p53 animals rapidly develop pro-B cell lymphomas
due to failure to complete V(D)J-mediated end joining
[79,93,94]. This DNA repair defect results in translocation
of IgH with c-myc (N-myc in the case of artemis; [91]) and
During class-switch recombination, AID-induced breaks are repaired by the DSB repair proteins such as Mre11/Nbs1/Rad50,  H2AX, Mdc1, 53BP1, and components of the NHEJ apparatus (Ku70, Ku 80, DNA-PK) Figure 3
During class-switch recombination, AID-induced breaks are repaired by the DSB repair proteins such as Mre11/Nbs1/Rad50, 
H2AX, Mdc1, 53BP1, and components of the NHEJ apparatus (Ku70, Ku 80, DNA-PK). Failure to perfom DSB repair activates 
ATM, leading to p53 stabilization. Alternatively, breaks are resolved by translocations often involving c-myc. These transloca-
tions are suppressed by ATM or by activation of the p19-dependent pathway leading to the activation of p53, resulting in 
checkpoint arrest and cell death. Adapted from reference 88 with permission.Cell Division 2006, 1:19 http://www.celldiv.com/content/1/1/19
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the resulting amplification of c-myc  through breakage
fusion bridge cycles [93,94]. Like NHJE/p53  animals,
53BP1/p53  mutants develop, albeit at a reduced fre-
quency, pro-B lymphomas with clonal translocations
between IgH and c-myc [14]. Because pro-B cell lympho-
mas (IgM-) are indicative of a failure to successfully com-
plete V(D)J recombination, this suggests that 53BP1
participates in some aspect of this process. In support of
this, some 53BP1/p53  T lineage tumors harbor clonal
translocations at the TCRα locus [14]. Although V(D)J
defects in 53BP1-/- cells have not been detected by stand-
ard measurements [54,78], subtle defects below the levels
of assay detection may be selected for during T cell expan-
sion.
The remainder of 53BP1/p53 T cell lymphomas possessed
clonal translocations in chromosomes that do not possess
antigen receptor loci or were aneuploidy with little signs
of DNA breaks [54,78]. With respect to the latter, 53BP1
tumor suppression resembles p53-driven aneuploidy, a
form of genomic instability linked to centrosome hyper-
amplification. Despite this, 53BP1-/- cells have normal
centrosome numbers [14]. Thus, 53BP1 appears to sup-
press tumorigenesis by two distinct mechanisms: DSB
repair and aneuploidy (the latter of which occurs in a
manner distinct from p53-driven aneuploidy). How p53
suppresses aneuploidy remains an open question,
although some possible clues have emerged. In addition
to the cell cycle checkpoint defects reported for 53BP1-/-
cells [13,28,29], 53BP1 localizes to the kinetochore and
attaches to chromosomes improperly aligned at the met-
aphase plate [17]. Despite this, 53BP1-defective cells have
no apparent role in the mitotic spindle checkpoint [14].
Moreover, 53BP1 is hyperphosphorylated in M phase in
response to nocodazole [17], and this has been partially
attributed to the JNK kinase [95]. 53BP1 has also been
reported to associate with the anaphase promoting com-
plex subunit Cdc27 [96]. Deciphering the role of 53BP1 in
suppressing aneuploidy promises to lead to exciting con-
nections between DSB repair, cell cycle checkpoints, and
lymphomagenesis.
DNA damage signaling in yeast: learning from 
potential 53BP1 orthologues
On first glance, there appear to be no obvious orthologues
of 53BP1 in yeast. However, Rad9 and Crb2 in budding
and fission yeast, respectively, possess similar functional
elements (Tudor and BRCT) and parallel properties with
53BP1, despite low overall sequence homologies. There-
fore, DNA damage response mechanisms in yeast will be
instructive for understanding mammalian 53BP1 func-
tion. For example, Rad9 is phosphorylated in response to
DNA damage by yeast PIK kinases [97]. Interestingly, loss
of Dot1 (and therefore methylation of H3-K79) prevents
activation of Rad9 and decreases its localization to sites of
DSBs [98]. Inhibition of IR-dependent phosphorylation
of H2A yields cells with very minor checkpoint defects
[63,99,100]. Despite some interesting parallels between
53BP1 and Crb2, there are some distinct differences. For
example, the BRCT motifs of Crb2 are required for both
homo-oligomerization and IRIF formation [101], but the
sequences sufficient for this in 53BP1 lie upstream of the
GAR motif and in the Tudor domains, respectively (Fig.
1).
As in higher eukaryotes, phophorylation of yeast histone
2A (γ-H2A), occurs rapidly in response to DSBs, indicat-
ing that this event is highly conserved. The yeasts, how-
ever, do not possess orthologues to Mdc1 and BRCA1.
Yeasts defective in H2A phosphorylation have, at best,
mild defects in NHEJ and checkpoint signaling [63,99].
Rad9, Crb2, and 53BP1 (at least at low doses of IR) are
required for cell cycle arrest in response to DNA damage
[13,28,102]. In fission yeast γ-H2A recruits Crb2 to sites of
DNA damage [102]. Interestingly, the accumulation of
Crb2 at IRIF in fission yeast is dependent on both γ-H2A
and histone H4 methylation at K20 [63,103], a modifica-
tion that plays a role in DNA repair in fission yeast [63].
Crb2 IRIF formation appears independent of Dot1 activity
as this methyltransferase does not appear to exist in the
fission yeast genome [103]. Furthermore, in the absence
of both H2A and H4 K20 histone modifications, Crb2
activity remains largely functional [103]. Here an alter-
nate recruitment pathway appears sufficient for IRIF for-
mation and checkpoint activation. Such a pathway
requires CDK phosphorylation of Crb2 at T215. Crb2
phosphorylation at T215 phosphorylation is important
for its association with the BRCT protein Cut5, an ortho-
logue of mammalian TopBP1 [100]. Moreover, hypomor-
phic  crb2-T215A  cells have checkpoint maintenance
defects [100,102]. Therefore, multiple DNA damage sig-
nals are programmed into Crb2 function, allowing it to
coordinate DNA repair with cell cycle progression and
chromatin remodeling.
Summary
53BP1 plays an important role in DNA damage signaling
pathways through its ability to influence the function of a
variety of factors including ATM and p53 (Fig. 3). Impor-
tantly, 53BP1 participates in DNA repair through its role
as a tumor suppressor protein, particularly in cells of B
and T origin. Here, 53BP1 collaborates with H2AX and
Mdc1 to participate in a novel form of end joining termed
"anchoring". In this setting, 53BP1 is recruited to or near
sites of DSBs where it coordinates DNA repair in the con-
text of chromatin structure, most likely through the lan-
guage of a histone code. Whether 53BP1 participates in
chromatin remodeling events remains an open question.
Given its large size, multiple domains and various inter-Cell Division 2006, 1:19 http://www.celldiv.com/content/1/1/19
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acting partners, 53BP1 is well poised to operate as a medi-
ator in multiple DNA damage signaling events.
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